// App-Quantinova.ai

P111 : Clinical validation of a blood-based prognostic biomarker in Inflammatory bowel disease; towards personalised medicine in IBD

Researchers

Presenter

  • P Lyons

Principal Investigators

  • N/A

Medical Centers

  • University of Cambridge, Department of Medicine, Cambridge, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

Biomarkers

  • Cluster of differentiation 8A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved